(Q44260128)

1 December 2017

title

NS-398, a selective cyclooxygenase-2 blocker, acutely inhibits receptor-mediated contractions of rat aorta: role of endothelium (English)

1 reference

1 December 2017

0 references

Ayotunde S O Adeagbo

1

1 reference

1 December 2017

Darshana Patel

2

1 reference

1 December 2017

Abdallah Iddrissu

3

1 reference

1 December 2017

John Walker

4

1 reference

1 December 2017

Sridhar Thirumalai

5

1 reference

1 December 2017

Irving G Joshua

6

1 reference

1 December 2017

Dale Schuschke

7

1 reference

1 December 2017

Yang Wang

8

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

European Journal of Pharmacology

1 December 2017

published in

1 reference

1 December 2017

volume

458

1 reference

1 December 2017

issue

1-2

1 reference

1 December 2017

page(s)

145-154

1 reference

Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

NSAIDs: time to re-evaluate gut toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

YC-1 increases cyclo-oxygenase-2 expression through protein kinase G- and p44/42 mitogen-activated protein kinase-dependent pathways in A549 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Involvement of cyclooxygenase 2 (COX-2) in intrinsic tone of isolated guinea pig trachea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Effects of the selective cyclooxygenase-2 inhibitor nimesulide on vascular contractions in endothelium-denuded rat aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

The advent of highly selective inhibitors of cyclooxygenase--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Cyclopiazonic acid inhibition of the Ca2+-transport ATPase in rat skeletal muscle sarcoplasmic reticulum vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Interactions of PGH synthase isozymes-1 and -2 with NSAIDs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902693-6

10.1016/S0014-2999(02)02693-6

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference